(INO)—AZN testing Imfinzi/MEDI0457 combo in second-line H&N cancer: https://finance.yahoo.com/news/inovio-provides-medimmune-launch-combination-120000238.html MEDI0457 (f/k/a INO-3112) is a cancer vaccine targeting HPV-associated tumors, which AZN licensed in Aug 2015 (#msg-116078700).